phone icon (917) 310-3371 Book fluphenazine decanoate evaluation
Nao Medical

Long-acting fluphenazine

Fluphenazine Decanoate Injection Care in New York

Prescriber-led assessment and coordination for a long-acting phenothiazine antipsychotic.

Fluphenazine decanoate is a long-acting antipsychotic used for patients who need prolonged parenteral treatment. The current label allows intramuscular or subcutaneous administration and says dose and interval must be individualized. A shorter-acting fluphenazine trial may be advisable when prior response is unknown. Nao confirms the prescriber-led plan before administration.

Nao Medical patient consultation
Nao Medical clinical visit
Nao Medical clinic interior
Evaluation comes before treatment A virtual psychiatric evaluation comes first. Product, order, delivery, staff, and site are confirmed separately.

Fluphenazine decanoate requires an individualized maintenance plan

The current label is explicit that no precise conversion formula fits every patient and that response must be monitored carefully.

Long-acting role

The medicine is intended for patients who require prolonged parenteral neuroleptic therapy, including people with chronic schizophrenia.

Prior response

When a person has not taken a phenothiazine, a shorter-acting fluphenazine form may be used first to assess response and an appropriate dose.

Route and timing

The current label allows intramuscular or subcutaneous administration; maintenance effects and intervals vary by patient.

Experienced oversight

The label calls for physician direction and facilities for periodic hepatic, renal, and blood monitoring outside institutional settings.

How the care team reviews a fluphenazine decanoate plan

The record should explain prior exposure, current stability, dose rationale, monitoring, and responsibility for follow-up.

1. Establish treatment history

Review prior oral or short-acting fluphenazine, other antipsychotics, response, adherence, side effects, diagnosis, and current symptoms.

2. Confirm individualized order

Document the dose, route, last administration, intended interval, next due date, and the psychiatric prescriber responsible for changes.

3. Review monitoring and access

Assess movement, blood-pressure, sedation, falls, seizures, blood counts, liver and kidney history, benefits, delivery, and site capability.

4. Administer and reassess

Document the administration route and dose, monitor immediate concerns, and maintain psychiatric and physical monitoring over time.

What to prepare for the first evaluation

Complete records reduce avoidable delays and help the clinician separate a new decision from continuation of an established plan.

  • Prior oral, short-acting, or depot fluphenazine records, including response and adverse effects.
  • Last injection date, dose, route, interval, next due date, and responsible prescriber information.
  • Movement symptoms, falls, seizures, blood pressure, blood counts, liver or kidney results, vision concerns, and current medicines.
  • Signed order, insurance, pharmacy, acquisition, and delivery information.

Safety, monitoring, and treatment boundaries

The clinical plan is individualized. These points highlight questions that need explicit review rather than replacing the current label, a full evaluation, or emergency care.

Movement disorders

Extrapyramidal symptoms and tardive dyskinesia can occur. Prompt review of new or worsening movements is important.

Blood and infection

The label discusses leukopenia, neutropenia, agranulocytosis, and blood-count monitoring, especially with prior low counts or drug-induced problems.

Falls and autonomic effects

Sleepiness, postural hypotension, motor instability, anticholinergic effects, and interactions with central nervous system depressants can increase risk.

Organ and eye monitoring

Long-term care may include hepatic, renal, blood, vision, and other monitoring based on the patient's risks and treatment history.

When to get urgent or emergency help

Get urgent help for high fever with severe stiffness or confusion, a seizure, serious infection symptoms with known low blood counts, collapse, trouble breathing, or immediate danger.

Virtual evaluation first, administration site confirmed later

Start with virtual psychiatry. The team reviews the medicine, order, dose history, delivery, trained staff, and site before scheduling an in-person injection. Do not arrange a shipment or travel to a clinic until the team confirms the plan.

Choose condition-focused care for diagnosis and long-term treatment planning. Choose a medicine-specific service for initiation, access, monitoring, delivery, or administration questions.

Haloperidol decanoate

Compare haloperidol decanoate's stable-oral-treatment, dosing, monitoring, and administration requirements.

Clinical and regulatory sources

These authoritative sources were checked on August 1, 2026. Drug labels and guidance can change, so the treating clinician uses current information for each decision.

Common questions about Fluphenazine decanoate

It is a long-acting antipsychotic intended for patients who require prolonged parenteral neuroleptic treatment, including people with chronic schizophrenia.
The current label allows intramuscular or subcutaneous administration. The prescriber's order and clinic protocol must specify the route.
The interval is individualized. The label notes that a maintenance dose may control symptoms for several weeks, but response and timing vary and must be monitored.
The label says it may be advisable for a person without prior phenothiazine exposure to receive shorter-acting fluphenazine first to assess response and establish an appropriate dose.
No. The label says no precise conversion formula applies to every patient. The prescriber must consider prior dosing, response, side effects, age, medical risks, and symptoms.
Monitoring may include movement symptoms, blood pressure, sedation and falls, blood counts, liver and kidney function, vision concerns, seizures, and other patient-specific risks.
Nao can review a valid outside order and records. Acceptance depends on a responsible prescriber, complete monitoring plan, medication access, delivery, and a confirmed site.
Contact the responsible prescriber promptly. Do not double, substitute, or restart a dose without a new review of timing, symptoms, and the treatment plan.
Book fluphenazine decanoate evaluation Call with questions

Updated August 1, 2026. This information does not replace an individual medical evaluation. A licensed clinician determines diagnosis, medication eligibility, prescribing, testing, dosing, administration, and follow-up.

Health information notice

General information only. This page is not medical advice and does not replace diagnosis, treatment, or guidance from a licensed clinician.

Content was updated August 1, 2026 from the sources cited on this page. Medical guidance, prescribing information, medication availability, and insurance rules can change. A licensed clinician must confirm current information and determine each patient's eligibility, testing, treatment, administration setting, and follow-up. Call 911 for a medical emergency. Contact Nao Medical with a question or correction.